Evidence map›Paper›PMID 20929366›Full record

ArticleInfection control and hospital epidemiology2010

Prevention of healthcare‐associated Clostridium difficile infection: what works?

Erik R Dubberke

Abstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Novel metal peroxide nanoboxes restrainBioengineering & translational medicine · 2023
    Article
  2. Strategies to preventInfection control and hospital epidemiology · 2023
    Article
  3. Article
  4. Fecal calprotectin concentrations in cancer patients with Clostridium difficile infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Article
  5. Article
  6. Infection prevention and control ofJournal of global health · 2016
    Review
  7. Article
  8. Prevalence and risk factors for asymptomatic Clostridium difficile carriage.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014
    Article
  9. Article
  10. Clostridium difficile O27 colitis: hospital-onset but community-acquired.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Erik R DubberkeDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, 660 S Euclid Avenue, St. Louis, MO 63110, USA. edubberk@dom.wustl.edu

Funding

C. DIFFICILE DISEASE IN STEM CELL TRANSPLANT RECIPIENTSK23AI065806 · NIAID · WASHINGTON UNIVERSITY · PI DUBBERKE, ERIK R · 2009 to 2011
$374k
NIAID NIH HHS K23 AI065806NIAID NIH HHS L30 AI062141
6 · The paper itself

Abstract

Prevention of Clostridium difficile infection has become extremely important because of increases in its incidence and severity. Unfortunately, efforts at C. difficile infection prevention are hampered by lack of data to support optimal prevention methods, especially for endemic C. difficile infection. Studies are needed to define the optimal prevention practices and to investigate novel prevention methods.

Indexed as

Clostridioides difficileCross InfectionEnterocolitis, PseudomembranousHumansIntensive Care Units

Identifiers

PMID20929366
PMCPMC3648222

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.